{"nct_id":"NCT02452372","title":"A Phase 1 Study of Givosiran (ALN-AS1) in Patients With Acute Intermittent Porphyria (AIP)","status":"COMPLETED","status_verified_date":"2018-06","start_date":"2015-05-06","start_date_type":"ACTUAL","primary_completion_date":"2017-09-06","primary_completion_date_type":"ACTUAL","completion_date":"2017-09-06","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["ALNY"]}